Back
International Consolidated Airlines Group SA 10K Form
Sell
49
ICAGY
International Consolidated Airlines Group SA
Last Price:
$7.49
Seasonality Move:
-4.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ICAGY News And Ratings
See the #1 stock for the next 7 days that we like better than ICAGY
ICAGY Financial Statistics
Sales & Book Value
| Annual Sales: | $34.7B |
|---|---|
| Cash Flow: | $3.4B |
| Price / Cash Flow: | 1.92 |
| Annual Sales: | $2.65 |
| Price / Book: | 2.73 |
Profitability
| EPS (TTM): | 1.21250 |
|---|---|
| Net Income (TTM): | $3B |
| Gross Margin: | $8.2B |
| Return on Equity: | 75.81% |
| Return on Assets: | 6.71% |
International Consolidated Airlines Group SA Earnings Forecast
Key International Consolidated Airlines Group SA Financial Ratios
-
The Gross Profit Margin over the past 14 years for ICAGY is 23.61%.
-
The Selling, General & Administrative Expenses for ICAGY have been equal to 3.37% of Gross Profit Margin.
-
The Research & Development expenses have been 0.76% of Revenue.
-
The Interest Expense is 33.02% of Operating Income.
-
The Net Earning history of ICAGY is 8.51% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 11 years.
International Consolidated Airlines Group SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Passenger Airlines |
| Sector: | Industrials |
| Current Symbol: | ICAGY |
| Website: | iairgroup.com |
Debt
| Debt-to-Equity Ratio: | 1.41 |
|---|---|
| Current Ratio: | 0.78 |
| Quick Ratio: | 0.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.08 |
|---|---|
| Forward P/E Ratio: | 0 |
ICAGY Technical Analysis vs Fundamental Analysis
Sell
49
International Consolidated Airlines Group SA (ICAGY)
is a Sell
Is International Consolidated Airlines Group SA a Buy or a Sell?
-
International Consolidated Airlines Group SA stock is rated a SellThe current International Consolidated Airlines Group SA [ICAGY] share price is $7.30. The Score for ICAGY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.